Edmund J. Pezalla, MD,

Articles by Edmund J. Pezalla, MD,

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants

ByJan Berger, MD, MJ,Donald C. Balfour III, MD, FACP,Joseph E. Biskupiak, PhD, MBA,Jeffrey D. Dunn, PharmD, MBA,Dennis B. Liotta, MD, MBA,Geno J. Merli, MD, FACP, FHM, FSVM,Edmund J. Pezalla, MD,

December 26th 2014

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

ByJan Berger, MD, MJ,Donald C. Balfour III, MD, FACP,Joseph E. Biskupiak, PhD, MBA,Jeffrey D. Dunn, PharmD, MBA,Dennis B. Liotta, MD, MBA,Geno J. Merli, MD, FACP, FHM, FSVM,Edmund J. Pezalla, MD,

December 26th 2014

This article is the first in a 2-part series that summarizes the proceedings from a roundtable meeting that was conducted to discuss real-world considerations in nonvalvular atrial fibrillation and venous thromboembolism.

Latest Updated Articles

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants
Published: December 26th 2014 | Updated:
Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants
Published: December 26th 2014 | Updated:

Edmund J. Pezalla, MD,

Articles by Edmund J. Pezalla, MD,

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

Latest Updated Articles

Trending on AJMC

Respiratory Vaccination by the Numbers: COVID-19, Flu, and RSV

Inside the 24-Hour Reversal of SAMHSA Grant Cuts With NAMI's Jennifer Snow, MPA

Lipid Management Remains Central to Cardiovascular Risk Reduction in CKD

Anti-Inflammatory, Antioxidant-Rich Diets May Lower Skin Cancer Risk, Slow Biological Aging

Meta-Analysis Finds No Significant NSCLC Survival Differences With ICIs, but Trial Diversity Remains Limited